Evaluation of specific immune complexes in patients with pulmonary sarcoidosis.

U. Zinchenko (St. Petersburg , Russian Federation), A. Starshinova (St. Petersburg , Russian Federation), M. Filatov (St. Petersburg , Russian Federation), V. Burdakov (St. Petersburg , Russian Federation), S. Landa (St. Petersburg , Russian Federation), N. Denisova (St. Petersburg , Russian Federation), P. Yablonskiy (St. Petersburg , Russian Federation)

Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Session: Granulomatous disorders: heterogeneous diseases with variable management
Session type: Thematic Poster
Number: 3011
Disease area: Interstitial lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Zinchenko (St. Petersburg , Russian Federation), A. Starshinova (St. Petersburg , Russian Federation), M. Filatov (St. Petersburg , Russian Federation), V. Burdakov (St. Petersburg , Russian Federation), S. Landa (St. Petersburg , Russian Federation), N. Denisova (St. Petersburg , Russian Federation), P. Yablonskiy (St. Petersburg , Russian Federation). Evaluation of specific immune complexes in patients with pulmonary sarcoidosis.. 3011

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017

The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009

Detection of various autoantibodies in patients with pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Significance of circulating immune complexes in pulmonary tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004

Signs of MICA as an innate immune molecule potentially involved in vascular remodelling in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 86s
Year: 2007

Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009

Evaluation of the functional parameters in scleroderma cases with pulmonary involvement
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009

Investigation of the main complex hystocompatibility antigens in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 525s
Year: 2006

The pulmonary microbiome and immunological activity in IPF patients.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020


Study of the system of hemostasis in patients with chronic forms of pulmonary sarcoidosis (PS) with impairments of regional pulmonary blood circulation
Source: Eur Respir J 2006; 28: Suppl. 50, 537s
Year: 2006

Specific activation of non-classical Th1 cells in pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

Lung and blood Th1 and Th17 responses against mycobacterial antigens in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - T-cell subsets
Year: 2011


Microbes mediated host innate immune response in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016

Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003

Angiogenic activity of sera from patients with various types of pulmonary fibrosis in relation to pulmonary functions
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


Specific blood immune response to haemophilus in stable COPD patients
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008